Advancements in Superparamagnetic Iron Oxide Nanoparticles for Magnetic Hyperthermia as a Promising Strategy to Combat Antibacterial Resistance Authors: Shashwat Sharma, Chien-Hung Lai, Chinmaya Mutalik, Yueh-Ying Hsieh, Tsung-Rong Kuo Published: 2026 ABSTRACT AbstractAntimicrobial resistance and biofilm-associated infections increasingly undermine the efficacy of conventional antibiotic therapy, creating a need for localized treatments that combine complementary physical and chemical antibacterial mechanisms. Superparamagnetic iron oxide nanoparticles (SPIONs) are particularly attractive because they can be magnetically targeted, surface-functionalized, imaged, and remotely activated using an alternating magnetic field (AMF). This Review critically examines SPION-mediated antibacterial magnetic hyperthermia, encompassing nanoparticle synthesis, control of magnetic properties, bactericidal mechanisms, multimodal therapeutic strategies, biosafety, and clinical translation. Particular emphasis is placed on how particle size, morphology, crystallinity, magnetic anisotropy, surface chemistry, aggregation state, AMF amplitude and frequency, specific absorption rate, and intrinsic loss power collectively determine heating efficiency and antibacterial efficacy. Beyond direct thermal damage, magnetic activation can disrupt bacterial membranes and proteins, destabilize biofilm matrices, enhance antibiotic penetration, interfere with quorum sensing, and promote catalytic reactive oxygen species generation. Emerging therapy platforms further integrate magnetothermal heating with other multimodal antibacterial therapies. Despite these advances, clinical translation remains constrained by heterogeneous nanoparticle accumulation, and standardisation of the magnetothermal parameters. Addressing these challenges through reproducible nanoparticle engineering, standardized AMF reporting, rigorous biosafety assessment, and clinically relevant infection models will be essential for advancing SPION-mediated magnetic hyperthermia toward practical antibacterial applications.Keywords: antibacterial resistance, iron oxide, magnetic hyperthermia, magnetic nanoparticle, SPIONs Introduction Bacterial infections represent a critical and escalating global health challenge, significantly impacting public health and the world economy.1 Treating antibiotic-resistant infections alone is projected to surpass $100 trillion by 2050 if current trends persist.2,3 This stark economic forecast encompasses direct healthcare costs, loss of productivity, and the broader societal impacts of prolonged illness and mortality. Furthermore, bacterial infections substantially contribute to morbidity, leading to long-term health complications and a diminished quality of life for survivors.4 A pivotal factor exacerbating the burden of bacterial infections is the rapid emergence and dissemination of antibiotic-resistant bacteria.5 The excessive and inappropriate use of antibiotics in both human medicine and agriculture has contributed to the development of resistance mechanisms in bacterial pathogens, leading to their increased ability to withstand those medications.6 Multi-drug resistant (MDR) strains, which exhibit resistance to multiple antibiotics, and extensively drug-resistant (XDR) strains, which are resistant to nearly all available antibiotics, pose significant challenges to treatment.7 The inefficacy of conventional antibiotics against these resistant strains has led to a surge in healthcare costs, prolonged hospitalizations, and elevated mortality rates.8 This crisis underscores the urgent need for novel antimicrobial therapies that can effectively combat resistant bacterial infections. Despite substantial progress in antibacterial nanomedicine, current therapeutic strategies remain limited by modality-specific constraints. Conventional antibiotics are increasingly compromised by multidrug resistance, poor penetration into mature biofilms, and recurrent infection following incomplete bacterial eradication. Photothermal and photodynamic therapies can provide localized bacterial killing, but their effectiveness is restricted by limited light penetration, oxygen dependence, uneven energy distribution, and potential damage to surrounding tissues at high irradiation intensities.9 Chemodynamic and nanozyme-based approaches enhance reactive oxygen species generation, although their activity is often strongly dependent on local pH, hydrogen peroxide availability, catalytic stability, and the composition of the infection microenvironment.10 Magnetomechanical systems can disrupt biofilm architecture and bacterial membranes, but their therapeutic outcome depends on nanoparticle anisotropy, field geometry, and efficient particle contact with the target biofilm.11 Drug-delivery nanocarriers improve local antibiotic accumulation, yet they may still rely on conventional antimicrobial agents and therefore do not eliminate the risk of resistance development.12 Moreover, many existing platforms lack deep-tissue activation, precise external control, real-time imaging capability, and the ability to integrate thermal, mechanical, catalytic, and drug-sensitizing effects within a single system.13 These unresolved limitations highlight the need for a remotely activated antibacterial strategy that can penetrate deep tissues, deliver spatially confined energy, disrupt biofilms, enhance antibiotic susceptibility, and support multifunctional theranostic treatment.14 Magnetic hyperthermia therapy (MHT) is a promising therapeutic approach to address the challenges and limitations of traditional antibiotic treatments, particularly in the context of antibiotic resistance.15 MHT involves the use of magnetic nanoparticles (NPs; MNPs) that can be targeted to infection sites and subsequently exposed to an alternating magnetic field (AMF). This exposure induces localized heating through hysteresis losses and Néel and Brownian relaxation mechanisms within the NPs, resulting in temperatures that can lethally affect bacterial cells or enhance the efficacy of co-administered antibiotics.16,17 The concept of hyperthermia as a therapeutic modality is not new; it has been extensively explored in oncology to selectively ablate tumor cells. However, its application in treating bacterial infections is relatively novel and offers several distinct advantages.18 Unlike broad-spectrum antibiotics that indiscriminately affect beneficial microbiota and pathogenic bacteria, MHT provides a targeted approach, thereby minimizing collateral damage to surrounding healthy tissues and reducing systemic side effects.19 Beyond direct thermal bacterial killing, localized heating disrupts bacterial membrane integrity, induces protein denaturation, increases membrane permeability, and facilitates antibiotic penetration, through multimodal therapies, thereby improving bacterial susceptibility to combination therapies.20 Additionally, localized heating can disrupt bacterial biofilms, which are complex communities of bacteria that exhibit heightened resistance to antibiotics and are implicated in chronic infections.21 Superparamagnetic Iron Oxide Nanoparticles are at the forefront of the MHT based antibacterial therapy. Recent studies further indicate that SPION-mediated magnetic hyperthermia can synergistically enhance reactive oxygen species (ROS) generation and catalytic antibacterial activity, providing multiple complementary mechanisms for bacterial eradication while reducing the likelihood of resistance development.22 Nevertheless, therapeutic performance remains highly dependent on nanoparticle engineering and magnetic heating efficiency, emphasizing the importance of optimizing SPION physicochemical properties and AMF parameters to facilitate safe and effective clinical translation. Collectively, these advantages position SPION-mediated magnetic hyperthermia as a versatile antibacterial platform that integrates localized thermal ablation with catalytic, oxidative, and drug-sensitizing mechanisms, providing a strong foundation for next-generation multifunctional nanotherapeutics against antimicrobial resistance.23 This review highlights the relationships among SPION synthesis, physicochemical and magnetic properties, AMF parameters, heating performance, and antibacterial efficacy, with particular emphasis on biofilm eradication, multimodal magnetothermal mechanisms, biosafety, and translational challenges. It further compares conventional magnetic hyperthermia with emerging magneto mechanical, nanozyme-assisted, catalytic, ROS-mediated, and drug-delivery strategies to identify current limitations and priorities for the clinical development of SPION-based antibacterial therapies. Superparamagnetic Iron Oxide NPs (IONPs; SPIONs) SPIONs exhibit unique magnetic properties that make them particularly suitable for hyperthermia applications.24 SPIONs are generally composed of magnetite (Fe3O4) or maghemite (γ-Fe2O3), which are superparamagnetic materials when their size is reduced to the nanometer scale.25 This property allows SPIONs to not retain magnetization in the absence of an external magnetic field, preventing unwanted aggregation and enhancing their stability in biological environments.26 SPIONs can be designed with optimal sizes, shapes and surface chemistry to maximize their heating efficiency and biocompatibility.26 The ideal size of SPIONs used in hyperthermia is typically 10–30 nm in diameter. At this scale, the NPs have high surface area-to-volume ratios that improve their interaction with bacterial cells and efficient heat generation under an AMF.27,28 Furthermore, SPIONs can be conjugated with different targeting ligands such as antibodies, peptides or small molecules to ensure a targeted delivery to specific bacterial pathogens or biofilms.29 The magnetic properties of Fe3O4 NPs, which are very important for their ability to generate heat in magnetic hyperthermia, are directly affected by the location and interaction of ferric and oxygen ions30 within the crystal lattice as shown in Figure 1. Fe3O4 has a special spinel structure, where the ferric ions are arranged at tetrahedral and octahedral sites, resulting in strong magnetic interactions.26 These interactions allow the formation of magnetic domains that can efficiently switch their magnetization in the presence of an AMF.31 This reversal of magnetization dissipates energy as heat, and thus explains the effective thermal generation in Fe3O4 NPs for magnetic hyperthermia.32 Explanation of the magnetic character of Fe3O4 in response to an alternating magnetic field. Created with BioRender.com. The antibacterial activity of the SPIONs under AMF is attributed to several effects resulting from the heat generated by the SPIONs.33 These include direct thermal damage to bacterial cells, disruption of biofilms and enhanced immune response.34 The thermal energy can denature bacterial proteins, disrupt membrane integrity, and induce oxidative stress, which causes cell death.35 Heating at the site further increases the permeability of bacterial cell membranes, thus allowing the uptake of co-delivered antibiotics and enhancing their antimicrobial effects. Underlying Mechanisms for SPION-Mediated Hyperthermia The efficacy of SPION-mediated hyperthermia is predicated on several key scientific mechanisms. The heat generated by SPIONs under an AMF is primarily due to hysteresis losses and the Néel and Brownian relaxation mechanisms.36 Hysteresis losses occur as the magnetic moments of the NPs attempt to align with the oscillating magnetic field, resulting in energy dissipation as heat.37 The Néel relaxation mechanism involves the reorientation of magnetic moments within the NPs, while Brownian relaxation pertains to the physical rotation of the entire NP in response to the magnetic field.38 Furthermore, The selection of appropriate magnetic field parameters is crucial for optimizing the therapeutic efficacy of MHT. The frequency of the AMF typically ranges from 100 kHz to 1 MHz, and the amplitude ranges 5–15 kA/m.30 These parameters must be carefully balanced to achieve sufficient heating without causing excessive non-specific heating of surrounding tissues.39 Additionally, the concentration of SPIONs at the target site is a critical determinant of therapeutic outcomes, necessitating efficient targeting strategies to maximize the accumulation of NPs at the infection site.40,41 The therapeutic outcome of SPIONs as a thermal ablation of bacterial pathogens is not only determined by the macroscopic temperature elevation of a nanoparticle suspension. Instead, bactericidal efficacy depends on the localised thermal dose delivered directly to the bacterial cell wall as well as in the viscoelastic microenvironment of the biofilm matrix. Specific absorption rate (SAR) and intrinsic loss power (ILP) provide complementary measures of SPION heating performance. SAR describes the heat generated per unit mass of magnetic material, whereas ILP partially normalizes SAR for differences in alternating magnetic field amplitude and frequency. ILP is most informative within the linear-response regime and should not be treated as an invariant material constant because aggregation, nonlinear magnetization reversal, and magnetic saturation can alter the expected field dependence. Accordingly, both parameters should be reported with particle concentration, normalization basis, dispersion medium, AMF conditions, and exposure duration. Experimental studies demonstrate that heating efficiency cannot be predicted from saturation magnetization or particle size alone. Kallumadil et al reported maximum ILP values of approximately 3.1 nH m2 kg−1 for commercial colloids containing 12 nm crystallites and 70 nm hydrodynamic particles, while nominally similar production batches exhibited different ILP values because of variations in crystallite size.42 Ansari et al subsequently identified a nonlinear dependence of ILP on SPION size and dopant composition, with midsized Mn-substituted ferrites providing the most favorable operating region; ILP correlated more strongly with coercivity and remanence than with saturation magnetization.43 Surface engineering is similarly important: Vassallo et al showed that coating-induced improvements in dispersion increased heating by modifying aggregation and magnetostatic interactions. Nanocubes can also produce exceptionally high SAR through enhanced anisotropy and hysteretic losses.44 For antibacterial applications, SAR and ILP are useful only when they translate into an effective thermal dose within the biofilm. Nguyen et al demonstrated that SPION-mediated heating dispersed Pseudomonas aeruginosa biofilms and, when combined with gentamicin, produced an approximately 2-log reduction in viable biofilm and planktonic cells.45 Future antibacterial studies should therefore correlate SAR and ILP with biofilm-localized temperature, bacterial log reduction, antibiotic sensitization, and host-cell safety rather than reporting final bulk temperature alone. Antibacterial Mechanism of Action of SPIONs The mechanism of action of Fe3O4 NPs as antibacterial therapeutics is multifaceted and involves several key processes (Figure 2). One primary mechanism includes the generation of reactive oxygen species (ROS)46 and Fenton-like reactions.47 Upon interaction with biological environments, the ROS generated initiate a genotoxic mechanism that results in DNA damage. Additionally, Fe3O4 mimics peroxidase-like activity through the Fenton reaction, catalyzing the decomposition of hydrogen peroxide (H2O2) to produce highly reactive hydroxyl radicals (•OH) and superoxide radicals (O2•-). These ROS play a pivotal role in inducing oxidative stress within bacterial cells Notably, IONPs compromise the integrity of bacterial cell walls where ROS can oxidize lipids, leading to lipid peroxidation and disruption of membrane integrity. A microscopic analysis revealed the direct interaction between IONPs and cell walls of Staphylococcus aureus (S. aureus).48 Through electrostatic interactions, Fe3O4 NPs adhere to the bacterial cell surface, leading to disruption of membrane integrity and permeability.46 This disruption compromises the structural integrity of the bacterial membrane, causing leakage of intracellular components and eventual cell lysis.49 Furthermore, ROS-induced oxidative stress can cause protein denaturation and DNA damage, ultimately resulting in bacterial cell death. Explanation of the underlying antibacterial mechanisms of magnetic hyperthermia-based iron oxide nanoparticles. Created with BioRender.com. Fe3O4 NPs also possess a high surface area and can directly interact with bacterial cell membranes. Metal ions exhibit a propensity to bind with thiol (-SH), amino (-NH), and carboxyl (-COOH) groups of proteins, including enzymes, leading to their inactivation or partial inhibition.50 Additionally, IONPs were found to suppress expressions of antibiotic resistance genes (ARGs) in antibiotic-resistant bacteria typically encountered in clinical settings.49 Mechanistic insights suggest that IONPs disrupt the function of F0/F1-ATPase, impeding H+ flow across membranes and altering the redox potential.51 Such antimicrobial actions attributed to IONPs are consistent across various studies and are shared by other metal oxide NPs.52 Moreover, NPs with smaller dimensions were implicated in inhibiting DNA replication through inactivating topoisomerases.53 Electron microscopic studies indicated direct interaction of Fe2O3 NPs with cell walls of Escherichia coli (E. coli).54 IONPs can penetrate the cytoplasm, accumulate, induce vacuole formation, and disrupt cell walls. Fe3O4 IONPs exhibit distinct antimicrobial mechanisms, particularly effective against gram-negative bacteria due to their ability to concentrate between the outer and inner membranes of bacterial cell walls.55 This concentration is facilitated by the binding of Fe3O4 IONPs to the formate hydrogen lyase (FHL) complex in the inner membrane, enhancing their antimicrobial efficacy against these bacteria.51 The bactericidal and antibiofilm activities of Fe3O4 IONPs are well-documented. For instance, positively charged and neutral IONPs significantly reduce Streptococcus mutans biofilms more effectively than negatively charged IONPs, likely due to better electrostatic interactions with the bacterial cell surface.56 Moreover, Fe3O4 IONPs coated with oleic acid prevented biofilm formation by S. aureus and Pseudomonas aeruginosa, suggesting that surface modifications can enhance the antibiofilm properties of these NPs.57 The physicochemical characteristics of IONPs, including surface charge, hydrophobicity, and a high surface area-to-volume ratio, facilitate their adsorption onto and penetration into bacterial biofilms, disrupting the biofilm matrix and impairing bacterial communication and survival.58 Beyond the intrinsic oxidative, membrane-disruptive, and antibiofilm effects described above, recent magnetic nanoplatforms increasingly exploit the simultaneous generation of thermal, mechanical, and catalytic stresses. These mechanisms are closely interconnected because the same Fe3O4-based platform can produce heat under an alternating magnetic field, undergo field-driven displacement or rotation, and catalyze ROS formation through iron-mediated reactions. Luo et al developed hyaluronic acid-coated MnFe2O4 nanoparticles that combined magnetic hyperthermia with quorum-sensing interference.59 Downregulation of agrA, agrC, and hld weakened bacterial stress responses, improved nanoparticle penetration, and enhanced treatment in an implant-associated infection model. Mesoporous Fe3O4 nanoparticles loaded with IR-820 similarly combined AMF-induced heating with photodynamic ROS generation, resulting in improved biofilm disruption and bacterial clearance in infected wound and subcutaneous abscess models.60 These approaches illustrate how modulation of the biofilm microenvironment can enhance magnetothermal efficacy without relying exclusively on high bulk temperatures. Compared to traditional magnetothermal damage, magnetomechanical systems exploit field-driven torque, oscillation, or rotation (Figure 3). Šavli et al used anisotropic iron oxide nanochains under a rotating magnetic field to remove more than 90% of selected Gram-negative biofilms, although the principal outcome was physical detachment rather than bacterial killing.61 By comparison, Fe3O4@polydopamine nanospears concentrated mechanical stress at the bacterial envelope, producing membrane puncture and enhanced S. aureus killing when combined with localized heating.62 These findings demonstrate that particle geometry and field mode determine whether magnetic actuation primarily causes matrix disruption, bacterial dispersal, or irreversible membrane injury. Multimodal therapies deployed with SPIONS based magnetic hyperthermia. Fe3O4-based platforms may also function as magnetically responsive nanozymes (Figure 3). He et al showed that magnetic stimulation enhanced the peroxidase-like activity of iron oxide nanoparticles, indicating that localized magnetic energy can accelerate catalytic reactions without a pronounced increase in bulk temperature.63 Ma et al translated this principle into a magneto-nanozyme platform in which magnetic assembly, AMF heating, and multivalent-iron catalysis promoted EPS degradation and ROS-mediated bacterial killing in a mouse skin-infection model.64 Copper-doped magnetic vortex nanorings further integrated magnetic hyperthermia, Cu-mediated chemodynamic therapy, and photothermal activation, producing near-complete elimination of E. coli and S. aureus under low-H2O2 conditions.65 Positively charged Fe3O4@Polyethyleneimine nanoparticles likewise accumulated within S. aureus biofilms and generated combined thermal, mechanical, and oxidative stress under AMF exposure.66 Furthermore, SPIONs have reported to establish multimodal mechanism with optical, catalytic, and immune-directed platforms and to identify the relative advantages and limitations of each approach. Koç et al combined aminolevulinic acid-loaded SPIONs with photothermal and photodynamic activation, producing 3–6-log reductions in Pseudomonas aeruginosa, 2–4-log reductions in Staphylococcus epidermidis, and up to a 13-log reduction in P. aeruginosa biofilms; however, light penetration and oxygen dependence may restrict application to deep infections. Ma et al developed an electromagnetically actuated magneto-nanozyme that integrated magnetic heating, mechanical biofilm disruption, and iron-mediated ROS generation, achieving 99.99% antibacterial efficacy in an MRSA-infected wound model while maintaining the treatment temperature at approximately 45 °C.64 Host-directed platforms provide a complementary strategy: a STING-adjuvanted P. aeruginosa outer-membrane-vesicle nanoparticle vaccine completely protected mice from lethal pneumonia at an antigen dose of 0.01 μg and reduced pulmonary bacterial burden by approximately 2 log units,67 whereas infection-responsive macrophage-targeted nanoparticles enhanced intracellular vancomycin delivery, ROS generation, bacterial clearance, and wound healing.68 Compared with these platforms, SPIONs offer deep magnetic-field penetration, remote activation, potential MRI guidance, and the capacity to integrate magnetothermal, magnetomechanical, catalytic, and drug-delivery functions. Their principal advantage therefore lies in providing a localized and externally controlled multimodal platform. Synthesis Techniques Fe3O4 NPs, owing to their unique size-dependent properties, have been applied across diverse fields; therefore, it is pivotal to understand fabrication methods to tailor these NPs to specific uses. Generally, Fe3O4 NPs are synthesized by two major routes: a top-down approach and a bottom-up approach. The top-down approach involves mechanical fractionation of bulk materials into smaller particles, achieved through techniques like milling or laser ablation. While effective, these methods may limit control over the particle size and shape. In contrast, the bottom-up approach builds NPs from molecular or atomic precursors. It encompasses both chemical and biological routes. Chemical methods utilize organic solvents as reaction media, allowing precise control over the size, composition, and surface properties. Examples include sol-gel synthesis and hydrothermal methods. Biological methods, on the other hand, leverage living organisms or their components. Green synthesis approaches minimize environmental impacts, making them attractive for sustainable NP production. Challenges include standardization, reproducibility, and optimization. Recent research focused on hybrid approaches, combining top-down and bottom-up methods. As we unravel the intricacies of these techniques, we pave the way for transformative applications in medicine, energy, and materials science. Physical Approaches Ball Milling Ball milling is a dominant method for the physical synthesis of Fe3O4 NPs. This technique utilizes the principles of impact and attrition to achieve solid-state size reduction, transforming iron precursors into refined NPs. The process employs a rotating cylindrical chamber filled with micron-sized grinding media, which mechanically fractures the precursor materials into NPs. The incorporation of solvents or excess salts can improve the milling efficiency and prevent agglomeration of the synthesized NPs.69 The ball mill process is described in Figure 3. Notably, advancements in ball milling have enabled the synthesis of magnetic catalysts, such as Cu/Fe/Fe3O4, through applying an auxiliary electromagnetic field during the milling process. It was established that the ball milling process plays a critical role in determining the morphology and electromagnetic absorption properties of the resulting NPs.70,71 Laser Ablation Laser ablation has emerged as an alternative to ball milling for MNP synthesis.72 This technique places the solid material below a thin sheet through which laser irradiation is applied from the top as illustrated in (Figure 4). This technique offers precise control over particle properties but suffers from limitations like low production rates and polydispersity.73 Unlike ball milling, laser ablation is simpler and requires no temperature or pressure adjustments. The laser power can be tailored to achieve the desired NP characteristics. For instance, the effects of laser power and solvent choice on Fe3O4/Au NP properties using neodymium-doped yttrium aluminum garnet (Nd:YAG) laser ablation highlight the potential for optimizing laser ablation parameters to address its limitations and facile NP synthesis.74 Illustration of the underlying mechanisms of the ball mill and laser ablation methods of synthesis. Created with BioRender.com. Sonolysis The sonolysis method, which utilizes ultrasonic waves to induce acoustic cavitation, is an efficacious technique for synthesizing Fe3O4 NPs. This process entails dissolving iron salts, such as FeCl2 or FeCl3, in an appropriate solvent, followed by ultrasonic irradiation.75 The implosive collapse of cavitation bubbles generates extreme localized temperatures and pressures, facilitating the nucleation and growth of Fe3O4 NPs. Critical factors influencing NP properties include the precursor concentration, pH, irradiation duration, and presence of surfactants.76 This method allows precise control over the NP size, shape, and surface characteristics, making it highly suitable for biomedical applications.77 Chemical Approaches Coprecipitation First deployed in 1981 by Massart et al, coprecipitation remains a gold standard in the industry due to its simplicity, ease, and efficacy.78 It uses the principle of the alkalization of metals, using homogeneous solutions containing the ions to be mixed and precipitated. Upon the addition of anions and a change in the pH, the desired NPs are precipitated, which are then washed and magnetically separated. The coprecipitation methos is well described in Figure 5. Coprecipitation route of synthesis of superparamagnetic iron oxide nanoparticles. Created with BioRender.com. A classic example of such synthesis is mixing ferrous and ferric salts in a stoichiometric ratio of 1:2 with the addition of bases like NaOH or NH4OH in an inert environment. This is generally described by the equation: Coprecipitation offers a robust and versatile approach for synthesizing NPs with well-defined homogenous properties. This technique relies on a well-orchestrated sequence of two critical stages: nucleation and growth. During nucleation, a rapid yet crucial event, precursor ions assemble in a supersaturated reaction medium to form minute, stable clusters.79,80 This initial particle formation, driven by the thermodynamic instability of the supersaturated state, lays the foundation for the final NP characteristics. The subsequent growth stage, typically slower and more controlled, involves the diffusion of dissolved precursor species from the bulk solution towards the existing NPs, leading to a gradual increase in their size. Crucially, the success of this method hinges on the meticulous control of reaction parameters. The molar ratio of the starting salts and the solution pH (8–14) play pivotal roles in influencing the rates of both nucleation and growth.81 These parameters ultimately dictate the final morphology and size distribution (monodispersed nature) of the synthesized NPs.29 For instance, studies suggested that a judicious selection of the molar ratio can promote the formation of specific crystal phases within the NPs. Additionally, the influence of temperature on the coprecipitation process cannot be overlooked. Elevated temperatures (above 80 °C) were reported to be particularly beneficial for synthesis, potentially by enhancing the diffusion kinetics of precursor species and promoting the formation of well-defined morphologies.82 Several modifications have been made to the coprecipitation method referred to as modified coprecipitation methods. They involve the addition of different surfactants or stabilizers making IONPs more adaptable and versatile. For instance, the addition of polyethylene glycol (PEG) 4000, not only improved the antibacterial activities against E. coli and S. aureus but also prevented the agglomeration by reducing the particle size from 17 to 12.2 nm.83 Similarly other stabilizers like chitosan84 and glycol chitosan,85 and polysaccharides like dextran and sucrose86 were also deployed to enhance the stability as well as evaluate the antibacterial performance giving an edge to surfactant-coated NPs compared to traditional ones. Furthermore, utilizing the coprecipitation route of synthesis, various antibacterial drugs were also loaded onto Fe3O4 NPs, delivering a synergistic antibacterial effect with hyperthermia. For example, Al-Jabari et al synthesized Fe3O4@SiO2 NPs and loaded levofloxacin to test it against a panel of gram-positive and gram-negative bacteria by an agar-well diffusion method. Similarly, antibacterial drugs like streptomycin87 and ampicillin88 were also adsorbed onto the surface of functionalized IONPs, making them an advanced nanocarrier for antibacterial drug delivery. Hydrothermal Method Hydrothermal methods, or solvothermal synthesis, have emerged as an effective way to synthesize Fe3O4 NPs due to their versatility and controllability.89–92 These techniques exploit the unique properties of water at elevated temperatures and pressures. Under such conditions, water exhibits enhanced reactivity, facilitating the dissolution of iron precursors (eg, FeCl2, FeCl3, Fe(NO3)3, or Fe2O3) and accelerates overall reaction kinetics. Furthermore, high pressures in the system further promote this effect fostering the formation of well-defined Fe3O4 crystals.93,94 However some researchers also used solvents like triethylene glycol to synthesize advanced NPs of Fe3O4 and CuFe2O4 resulting in NPs with higher magnetism curves and hyperthermia.95 The hydrothermal synthesis process involves a well-defined sequence, as shown in Figure 6. First, iron precursors are dissolved in deionized water, and the solution is sealed within a Teflon-lined autoclave. The autoclave subjects it to high temperatures (typically 150–300 °C) and elevated pressures for a predetermined time in a closed environment. Finally, the Fe3O4 NPs are separated and dried using magnetic separation or centrifugation. Hydrothermal route of synthesis of superparamagnetic iron oxide nanoparticles. Created with BioRender.com. This approach offers several advantages including simplicity, scalability due to readily available equipment and precursors, and the ability to tailor the size, morphology, and crystallinity of the NPs through meticulous control of reaction parameters (temperature, pressure, and reaction time).96–98 Additionally, the use of water as the solvent and a closed autoclave system minimizes contamination, leading to high-purity Fe3O4 NPs. However, precise control over NP characteristics necessitates careful optimization of reaction conditions, and operating at high pressures and temperatures demands robust equipment and strict adherence to safety protocols. Various researchers have deployed the hydrothermal-based synthesis of Fe3O4 for the development of nanomaterials in the domains of antibacterial and anticancer therapeutics. For example, Wei et al synthesized iron oxide-based Fe3O4@MoS2-Ag NPs using hydrothermal synthesis with a recoverable peroxidase-like effect resulting into antibacterial activities.99 Jabir et al synthesized PEG-coated Fe3O4@PEG NPs to induce an apoptotic effect against cancer. The PEG coating not only stabilized and reduced the average particle size from 9–20 to 5–12 nm but also was twofold more cytotoxic towards the AMJ13 breast cancer cell line with respective 50% inhibitory concentration (IC50) values of 36.53 and 18.23 mmol.100 Similarly hyaluronic acid used to prepare Fe3O4@HA NPs delivered a cytotoxic effect by selectively targeting overexpressed cluster of differentiation 44 (CD44) cells.101 Such modifications also improved the hyperthermic effect by increasing the intrinsic power loss up to 25 times. Microemulsions Microemulsion method is a versatile technique for synthesizing Fe3O4 NPs, that utilizes thermodynamically stable mixtures of water, oil, and surfactants to create nanoscale reaction environments. In this method, iron salts such as FeCl2 or FeCl3 are dissolved in the aqueous phase, while the oil phase typically contains a hydrocarbon solvent.102 Surfactants stabilize the interface between the water and oil phases, forming microemulsions. Upon mixing, reduction and nucleation of Fe3O4 occur within confined microemulsion droplets, allowing for controlled NP growth. The resultant Fe3O4 NPs exhibit uniform size and shape due to the constrained reaction environment. Critical parameters influencing synthesis include the type and concentration of surfactants, water-to-oil ratio, and reaction temperature.103 Post-synthesis, NPs are recovered through magnetic separation or centrifugation, followed by washing. This method enables precise control over NP characteristics, making it suitable for biomedical and catalytic applications. Green Synthesis The green synthesis of Fe3O4 NPs represents a sustainable and environmentally friendly approach that utilizes natural plant extracts as reducing and stabilizing agents. This methodology presents several advantages over traditional chemical synthesis techniques, such as lower environmental impacts, cost-efficiency, and enhanced biocompatibility of the resulting NPs.104–109 The synthesis process generally involves the following steps. Initially, plant extracts are prepared by boiling plant materials (leaves, seeds, or bark) to extract bioactive compounds. Subsequently, the plant extract is mixed with an aqueous solution of an iron precursor, commonly FeCl3 or FeSO4. The bioactive compounds in the extract, which include polyphenols, flavonoids, and other antioxidants, serve as reducing agents, converting Fe3+ ions to Fe3O4 NPs.110 Concurrently, these compounds act as capping agents, stabilizing the NPs and preventing agglomeration.111 The NPs are then purified by centrifugation, followed by washing with distilled water and ethanol to ensure high purity. Finally, the purified NPs are collected and dried for further use. The principal advantages of green synthesis include its simplicity, scalability, and the utilization of non-toxic, renewable resources.111–113 This approach circumvents the use of hazardous chemicals, thereby reducing environmental pollution and associated health risks. Moreover, the biocompatibility of green-synthesized NPs makes them particularly suitable for antibacterial applications. The antibacterial efficacy of green-synthesized Fe3O4 NPs has been rigorously validated in multiple studies, demonstrating their potential in biomedical applications. For instance, Dhavale et al employed an extract from Sphagneticola trilobata to synthesize IONPs, which exhibited zones of inhibition ranging from 12 to 18 mm against various pathogenic bacteria.105 This significant antibacterial activity underscores the potential of these NPs in combating bacterial infections. Similarly, Majid et al utilized a Phoenix dactylifera seed extract for the green synthesis of Fe3O4 NPs, achieving a minimum inhibitory concentration (MIC) of 6 µg/mL against pathogenic bacteria, highlighting their strong antibacterial properties suitable for infection control and therapeutic applications. Various examples of different methods of synthesis of SPIONs in the realms of antibacterial diseases are highlighted in Table 1. Table 1Description of Different Routes and Examples of Fe3O4 Synthesis, Describing Morphological Advantages and Relative Ease of SynthesisNo.ReferenceSynthesis MethodRelative Ease of SynthesisParticle SizeMorphologyAdvantages1Dutta et al114Modified coprecipitation (gelatin grafting)Moderate10-20 nmSphericalBiocompatibility, enhanced drug delivery2Gahrouei et al115Ultrasonic irradiation-assisted coprecipitationEasy8-12 nmSphericalSimple synthesis, good control over size3Hajalilou et al116CoprecipitationModerate10-15 nmSphericalEnhanced heating efficiency4Hariharasuthan et al117CoprecipitationEasy10-12 nmSphericalEasy synthesis with particle size control5Jović Orsini et al118CoprecipitationModerate10-15 nmSphericalEnhanced magnetic properties6Karaagac and Köçkar119PEG coating via coprecipitationModerate8-12 nmSphericalImproved saturation magnetization7Kesse et al120Multicore-shell synthesisComplex20-30 nmMulticore-shellBioactivity, stability8Mondal et al121CoprecipitationEasy10-15 nmCore-shellImproved heating and optical properties9Popova et al122CoprecipitationEasy10-20 nmCore-shellpH-responsive drug delivery10Rezanezhad et al123Coprecipitation with a natural capping agentModerate12-18 nmSphericalBiocompatibility, natural capping agents11Shebha Anandhi et al124CoprecipitationEasy10-15 nmSphericalHigh heating efficiency12Alkhayal et al125PEG coating via coprecipitationModerate10-15 nmCube-likeEnhanced biocompatibility13Jeon et al126Multigranule nanocluster formationComplex30-50 nmMultigranularEnhanced hyperthermic efficacy14Kahil et al127Hydrothermal methodModerate15-20 nmSphericalEnhanced magnetic properties15Kurnaz Yetim et al128Silica coating via a sol-gel methodComplex20-30 nmCore-shellFluorescent properties16Li et al12Mesoporous hollow synthesisComplex50-100 nmHollowAntibacterial, antibiofilm activity17Reyes-ortega et al129Various morphologies via coprecipitationComplex10-20 nmVariousTunable magnetic properties18Soleymani et al101Hyaluronic acid coating via coprecipitationModerate10-15 nmSphericalTargeted cancer therapy19Wang et al130PVP coating via coprecipitationModerate10-15 nmNanotubesHigh heating efficiency20Cai et al (2020)104Modified green synthesisEasy15-20 nmCore-shellpH-responsive drug release21Ruíz-Baltazar et al111Ultrasound-assisted synthesis with Au and Ag decorationComplex15-25 nmSphericalAntifungal and antibacterial activities22Dhavale et al105Green synthesis using Sphagneticola trilobata extractEasy10-20 nmSphericalEco-friendly, biocompatible23Erci and Cakir-Koc112Green synthesis using Thymbra spicata leaf extractEasy8-15 nmSphericalAntibacterial, antioxidant activity24García et al106Green synthesis using orange wasteEasy10-20 nmSphericalEco-friendly, antibacterial25Joharian et al113Green synthesis using Eriobotrya japonica seed extractEasy15-25 nmCompositeAntibacterial activity26Majid et al107Green synthesis using Phoenix dactylifera seed extractEasy10-20 nmSphericalEco-friendly, antibacterial27Majid et al131Green synthesis using vegetable extractsEasy20-30 nmNanoflakesAntibacterial activity28Medina-Ramírez et al108CoprecipitationEasy10-20 nmCore-shellPhotocatalytic properties29Mohammed et al132Green synthesis using Olea europaea leaf extractEasy10-15 nmSphericalAntibacterial activity30Rajendrachari et al109Green synthesis using Tilia tomentosa leavesEasy10-20 nmSphericalAntibacterial activity31Sivakami et al133Green synthesis using Cinnamomum verum bark extractEasy10-15 nmSphericalBiocompatibility, antibacterial32Taufiq et al110Synthesis of Fe3O4/Ag nanohybridModerate20-30 nmHybridAntimicrobial, antifibrotic33Wang et al130Green synthesis using orange peel extractEasy10-20 nmSphericalAntibacterial activityAbbreviations: PEG, polyethylene glycol; PVP, polyvinylpyrrolidone; MRI, magnetic resonance imaging. Description of Different Routes and Examples of Fe3O4 Synthesis, Describing Morphological Advantages and Relative Ease of Synthesis Abbreviations: PEG, polyethylene glycol; PVP, polyvinylpyrrolidone; MRI, magnetic resonance imaging. Biocompatibility IONPs are renowned for their exceptional biocompatibility and biodegradability. However, their safety depends strongly on particle size, surface chemistry, dose, administration route, and exposure duration. After systemic administration, SPIONs rapidly acquire a plasma-protein corona and are preferentially sequestered by the mononuclear phagocyte system, particularly Kupffer cells in the liver and macrophages in the spleen. Subsequent endosomal–lysosomal degradation releases Fe2+/Fe3+, which can enter physiological ferritin, transferrin, and hemosiderin pools; however, clearance may require days to weeks and can be delayed by aggregation, dense coatings, repeated dosing, or high tissue burden. For example, an intravenous injection of 0.8 mg/kg body weight of γ-Fe2O4 NPs did not adversely impact the weight gain of rats or induce apoptosis in human umbilical vein endothelial cells (HUVECs).134 Following injection, these NPs were observed in the lungs, liver, and kidneys, but not in the brain or heart. Moreover, a substantial amount of the NPs was eliminated in the urine within 72 h. Generally, IONPs exhibit low or no cytotoxic effects on cell cultures. Coatings such as polyethyleneimine, dimercaptosuccinate, or citrate applied to IONPs did not adversely affect primary rat cerebellar cortex astrocytes or cultured murine astrocytes.135 Similarly, IONPs conjugated with PEG-phospholipids (WFION) did not impact the viability of the B16 F10 cell line at concentrations of up to 0.75 mg Fe/mL.136 Fe3O4 NPs were shown to have a bacteriostatic effect without causing hemolysis. In some cases, IONPs can enhance caspase-3-dependent apoptosis, generate ROS, cause membrane damage, and alter the cytoskeleton in HUVECs,137 although those cytotoxic effects generally occur at much higher concentrations than those needed for their antimicrobial properties. Several experimental studies indicate that the antibacterial benefit of SPION-mediated hyperthermia must be interpreted together with its effects on mammalian cells and surrounding tissues. Kim et al showed that antibody-conjugated magnetic nanoparticles could localize heating within Staphylococcus aureus-infected wounds, reduce bacterial burden, and accelerate wound closure without detectable damage to adjacent tissue, suggesting that pathogen targeting can improve the therapeutic window.138 Nguyen et al achieved only a modest temperature increase of approximately 5 °C in Pseudomonas aeruginosa biofilms, yet this was sufficient to promote biofilm dispersal and enhance gentamicin activity, supporting the use of mild hyperthermia rather than direct thermal ablation.45 Similarly, Almutairi et al reported that ferumoxytol-mediated heating combined with ciprofloxacin reduced S. aureus and P. aeruginosa burdens while producing limited systemic temperature elevation, indicating that localized treatment may preserve host tissue when the thermal dose is carefully controlled.139 Nevertheless, SPION toxicity is strongly formulation-dependent. Mesoporous and polyethyleneimine-functionalized Fe3O4 nanoparticles can improve bacterial adhesion and biofilm penetration, but their positive surface charge may also increase interactions with erythrocytes, fibroblasts, endothelial cells, and other mammalian membranes, potentially causing membrane disruption, oxidative stress, inflammation, or hemolysis.66 Ma et al maintained infected wounds near 45 °C and achieved high antibacterial efficacy through combined heating and catalytic ROS generation, whereas higher temperatures are more likely to damage regenerating tissue.64 This concern is particularly relevant to the microfiber system reported by Ansari et al, in which exposures above 50 °C enhanced MRSA killing but may compromise fibroblast viability, angiogenesis, collagen deposition, and wound repair.21 Magnetotactic bacteria-mediated targeting likewise improved bacterial attachment and killing, but biological carriers introduce additional considerations related to immunogenicity and inflammatory responses.140 Overall, SPIONs are not inherently selective for bacteria over mammalian cells; their apparent biocompatibility depends on local administration, surface coating, particle dose, AMF intensity, exposure duration, and the resulting thermal profile.141,142 From an antibacterial perspective, the most clinically realistic strategy is therefore to use mild, localized hyperthermia to sensitize biofilms and resistant bacteria to antibiotics or catalytic treatment while avoiding temperatures and nanoparticle concentrations that induce host-cell injury. Application of Magnetic Hyperthermia-Based IONPs as Antibacterial Agents Iron oxide-based magnetic hyperthermia is emerging as a highly promising approach in contemporary therapeutic modalities. Figure 7 illustrates the various theragnostic applications of magnetic hyperthermia as an antibacterial treatment strategy. Magnetic hyperthermia enables spatially confined energy deposition, while the associated temperature increase can weaken the extracellular polymeric substance matrix, increase bacterial membrane permeability, and facilitate antimicrobial penetration into biofilms. Distinct from the studies discussed above, Nickel et al (2020) evaluated shape-selected iron oxide nanoparticles loaded with cetyltrimethylammonium bromide and demonstrated that magnetic transport enhanced nanoparticle penetration through robust methicillin-resistant Staphylococcus aureus biofilms.143 Their findings further showed that nanoparticle morphology and surface charge strongly influenced the delivery of the biocide to bacteria located within deeper biofilm regions. For magnetically targeted antibiotic delivery, Geilich et al (2017) developed SPION-containing polymersomes coencapsulating methicillin, which penetrated approximately 20-μm-thick Staphylococcus epidermidis biofilms under an externally applied magnetic field.144 Confocal microscopy demonstrated loading-dependent bacterial killing, while SPION incorporation simultaneously increased the magnetic responsiveness and MRI relaxivity of the nanocarriers, supporting their potential use as theragnostic antibacterial systems. A related thermoresponsive mesoporous silica nano system employed surface-decorated SPIONs to generate localized heat and trigger the opening of antibiotic-loaded pores. Exposure of Escherichia coli biofilms to 200 μg mL−1 of the nanocarrier under a 202 kHz and 30 mT alternating magnetic field produced an approximately 4-log10 reduction in viable bacterial counts, illustrating the combination of magnetic hyperthermia and controlled antibiotic release represented in the schematic (Álvarez et al, 2022).145 Implant-associated infection control has also been demonstrated using a silk-fibroin-stabilized Fe3O4 nanoparticle coating applied to titanium surfaces. Magnetically induced detachment of the coating physically removed adherent biofilm and enhanced antibiotic efficacy by up to 100-fold in vitro and in a rat subcutaneous implant model, highlighting a mechanically assisted strategy for protecting implanted medical devices (Quan et al, 2024).146 For dental applications, Fe3O4/BiVO4 photoactive microrobot swarms were magnetically navigated across titanium implant surfaces, where their collective mechanical motion and light-triggered reactive oxygen species generation disrupted established biofilm colonies (Mayorga-Martinez et al, 2022).147 MRI-compatible magnetic nanocarriers additionally provide a theranostic route by combining field-directed accumulation, therapeutic delivery, anatomical localization, and treatment monitoring within a single platform, as demonstrated by the SPION-containing polymersomes reported by Geilich et al (2017).144 Magnetic resonance-guided mild hyperthermia has also been used to trigger localized ciprofloxacin release at approximately 42 °C in an infected-tissue model; however, this system employed low-temperature-sensitive liposomes activated by magnetic resonance-guided high-intensity focused ultrasound rather than SPION-mediated magnetic heating (Wardlow et al, 2016).148 Collectively, these findings support the central concept illustrated in the figure that SPION-based systems can integrate externally controlled physical activation, deep biofilm penetration, antimicrobial delivery, implant protection, and diagnostic imaging within a multifunctional antibacterial strategy. Various applications of SPIONs in modern day antibacterial therapy. These NPs can be engineered to selectively target pathogenic bacteria, enhancing the efficacy of hyperthermia-induced bacterial eradication while minimizing damage to healthy tissues. Their ability to function with various biological molecules ensures a high degree of specificity, significantly reducing off-target effects. Additionally, the biocompatibility of Fe3O4 NPs ensures minimal adverse reactions in the host organism, providing a safe and effective option for clinical use. Various antibacterial applications of iron oxide-based magnetic hyperthermia as a therapeutic modality are explained in Table 2.12,21,61,62,64,65,139,145,149–154 Table 2Recent Iron Oxide-Based Antibacterial Magnetic and Multimodal Platforms: Activation, Efficacy, Biosafety, and LimitationsNo.ReferencePathogenTherapeutic StrategyActivation ConditionsThermal/Magnetic PerformanceQuantitative ActivityMechanismBiosafety/TranslationMain Limitation1Li et al12E. coli, S. aureus; planktonic + biofilm; in vitroDirect AMF magnetothermal treatment0.5–1.0 mg/mL; 210 kHz, 2.5 kW; 25 minSAR/ILP NR; bulk heating alone did not explain killing1 mg/mL: 99.15% E. coli and 79.88% S. aureus CFU reduction; biofilm dispersionLocal heat + particle motion disrupted membranes/EPSAntibiotic-free proof-of-concept; no in vivo safety dataField amplitude, local temperature, thermal dose, SAR/ILP NR2Almutairi et al149S. aureus biofilm + intracellular bacteria in RAW264.7 cellsMild MHT + ciprofloxacin/vancomycin + macrophage clearance1-3 mg/mL; 18–30 kA/m, 2.1 MHz; 6 min; antibiotic 16 µg/mLΔT ~5-19 °C; mild CEM43 below skin-damage threshold; SAR/ILP NRMHT alone <1-log10; combination ~2-log10 (~99%) biofilm reductionHeat increased permeability/drug uptake; ROS supported macrophage killingLower thermal doses better tolerated; highest dose reduced macrophage viabilityIn vitro; high frequency; no SAR/ILP or in vivo distribution data3Wang et al153Implant S. aureus biofilm; in vitro + rat modelMHT + heat-triggered NO + innate-immunity regulationAMF 10 min; frequency/amplitude NRStrong heating; SAR/ILP/CEM43 NR5.83→3.34 log10 CFU/mm2: 2.49-log10 (~99.68%) reductionMHT opened biofilm, released NO, and activated macrophagesRat implant efficacy; addresses recurrence and host responseCobalt/NO long-term safety; incomplete AMF and SAR reporting4Ma et al64MRSA biofilm; in vitro + mouse skin infectionMagnetic microswarm + mechanical EPS removal + nanozyme/ROS + AMF2 mg/mL + 1% H2O2; 4 Hz rotation; AMF 15 minMagnetothermal enhancement; SAR/ILP NR96% biofilm removal; >6-log10 (>99.99%) in vitro killing; 99.99% in vivo efficacyShear removed EPS; polyvalent Fe/AMF amplified ROSMouse efficacy and biosafety testedHigh NP/H2O2 dose; complex control; AMF/SAR NR5Alvarez et al145E. coli biofilm; in vitroMHT-triggered antibiotic release200 µg/mL; 202 kHz, 30 mT; time NRHeating crossed PNIPAM transition (~40-43 °C); SAR/ILP NR~4-log10 (~99.99%) viable-biofilm reductionHeat uncapped pores, released levofloxacin, weakened EPSLocalized release may reduce systemic exposureSingle species; no in vivo study; time/SAR/thermal mapping NR6Almutairi et al149Dual S. aureus/P. aeruginosa biofilm; in vitro + diabetic mouse woundMild MHT + ciprofloxacin; metabolic reactivation1-2 mg/mL; 60 kA/m, 375 kHz; 10 min; ciprofloxacin 50 µg/mLΔT 5.3, 11.6, 16.1 °C at 1, 2, 3 mg/mL; CEM43 1/20 min; SAR/ILP NRIn vivo: ~2-log10 (~99%) S. aureus and ~3-log10 (~99.9%) P. aeruginosa reductionMild heat reactivated tolerant bacteria and restored drug susceptibilityClinically used ferumoxytol; diabetic wound modelHigh field; antibiotic-dependent; no SAR/ILP or human thermal-uniformity data7Luo et al152Implant biofilm; in vitro + in vivoQuorum-sensing inhibition + MHT + inflammation/tissue repairAMF used; dose, frequency, amplitude, time NRThermal profile and SAR/ILP NRStrong in vitro/in vivo activity; review-reported efficacy 95.8±1.05% (verify primary paper)agrA/agrC/hld suppression weakened heat defenses; HA aided repairIn vivo anti-inflammatory and regenerative effectsPrimary AMF/thermal metrics and long-term Mn/Fe clearance NR8Lu et al151MRSA biofilm; plates, catheters + mouse catheter modelMagnetic targeting + ultrasound cavitation + Fe3O4 nanozyme ROS1 mg/mL; 32 mT; ultrasound 1 MHz, 1 W/cm2, 50% duty, 10 minNon-AMF; SAR/ILP NA~5-log10 plate reduction; 5.6-log10 + 71.2% catheter biomass removal; ~3-log10 in vivoCavitation opened EPS; released Fe3O4 catalyzed ROSHUVEC viability >90%; hemolysis <5% at ≤2 mg/mL; catheter modelRequires ultrasound/H2O2; not MHT9Wang et al65E. coli, S. aureus; in vitro + mouse woundMHT + Cu-CDT + 808-nm PTT150 µg/mL; AMF NR; 808 nm; 1 mM H2O2AMF ΔT 18.2 °C, SAR 640.9 W/g; NIR ΔT 42.6 °C, PCE 46.45%Near-complete eradication reported; exact log/% NRCu2+ membrane injury + Fenton ROS + dual thermal damageMouse efficacy; good short-term biocompatibilityAMF details/ILP and long-term Cu retention NR10Li et al150S. aureus biofilm; in vitro + rat wound/abscessMHT + heat-triggered IR-820 release + PDT1 mg/mL; AMF 210 kHz, 2.5 kW, 18 A; 30 min in vitro/20 min in vivo; 710-nm lightFinal T ~40.3 °C loaded vs 43.6 °C unloaded; SAR/ILP NRAlmost complete biofilm/CFU clearance in vitro and in vivo; exact log/% NRMHT disrupted biofilm/released IR-820; light generated ROSL929 and hemolysis tests acceptable; two rat modelsExact efficacy, NIR dose, SAR/ILP and clearance NR11Ansari et al21MRSA; in vitro local-treatment modelLocalized MHT + sub-MIC doxycycline delivery14 mT, 592 kHz; 40 min; 50–55 °C for ~15 min; doxycycline 0.01–0.5 µg/mLCulture maintained at 50–55 °C; SAR/ILP NRUp to 35% greater activity than non-heated doxycycline; log reduction NRHeat sensitized MRSA to released sub-MIC drugPotentially scalable electrospun local deviceIn vitro only; >50 °C host-injury risk; leachables/degradation/SAR NR12Savli et al61E. coli, P. fragi, L. lactis biofilms; Caco-2 cellsRotating-field magnetomechanical detachment300/600 rpm; 30/60 min; two field strengthsNonthermal; SAR/ILP NA>90% E. coli and P. fragi removal; <90% L. lactis removalNanochain torque mechanically detached biofilmNo adverse effect on Caco-2 monolayersDetachment may release viable cells; nonpathogenic models; no in vivo data13Xu et al62Mainly S. aureus; biofilm; in vitro + simulationsRotating-field membrane puncture + NIR PTTField strength/rotation/NIR power/time NRPDA photothermal heating; SAR/ILP/thermal profile NRHighest killing and biofilm removal with RMF+NIR; exact log/% NRSharp tips focused mechanical stress; PDA heat amplified punctureMechanism supported by imaging and simulationsIncomplete dosimetry/in vivo safety; shape-control reproducibility14Yuwen et al154MRSA catheter biofilm; in vitro + mouse modelMagnetic targeting + ultrasound cavitation + sonodynamic ROSMagnetic field + ultrasound; detailed dosimetry NRNon-AMF; SAR/ILP NA58.8% biofilm removal; 4.1-log10 (99.992%) in vivo killingTargeting concentrated bubbles; cavitation opened EPS; MnCO3 generated ROSAntibiotic-free mouse catheter efficacyNeeds ultrasound access; clearance/repeat-dose safety/dosimetry NRNotes: NR indicates that the primary study did not report the parameter. Rotating-field, magnetic-targeting/ultrasound, and sonodynamic systems are identified as non-AMF comparator.Abbreviations: AMF, alternating magnetic field; CEM43, cumulative equivalent minutes at 43 °C; CDT, chemodynamic therapy; EPS, extracellular polymeric substances; ILP, intrinsic loss power; MHT, magnetic hyperthermia; NA, not applicable; NIR, near-infrared; NR, not reported; PDT, photodynamic therapy; PTT, photothermal therapy; SAR/SLP, specific absorption/loss rate. Recent Iron Oxide-Based Antibacterial Magnetic and Multimodal Platforms: Activation, Efficacy, Biosafety, and Limitations Notes: NR indicates that the primary study did not report the parameter. Rotating-field, magnetic-targeting/ultrasound, and sonodynamic systems are identified as non-AMF comparator. Abbreviations: AMF, alternating magnetic field; CEM43, cumulative equivalent minutes at 43 °C; CDT, chemodynamic therapy; EPS, extracellular polymeric substances; ILP, intrinsic loss power; MHT, magnetic hyperthermia; NA, not applicable; NIR, near-infrared; NR, not reported; PDT, photodynamic therapy; PTT, photothermal therapy; SAR/SLP, specific absorption/loss rate. Clinical Translation and Regulatory Pathways for SPION-Based Magnetothermal Antibacterial Therapy Clinical translation of SPIONs is most advanced in diagnostic imaging, iron replacement, sentinel-lymph-node mapping, and oncological hyperthermia, whereas antibacterial magnetic hyperthermia remains at an early stage. The clearest registered antibacterial precedent is NCT06110494, a completed randomized Phase 4 study in 44 patients with apical periodontitis that repurposed ferumoxytol with H2O2 as a topical root-canal nanozyme; however, its activity relied on catalytic ROS generation rather than AMF-induced heating.155 Other registered studies, including NCT07224464 and NCT04316091, investigate SPION-mediated magnetic treatment in advanced solid tumors and osteosarcoma, respectively,156,157 and therefore provide relevant experience in nanoparticle dosing, magnetic-field delivery, thermal monitoring, acute safety, and long-term follow-up without establishing antibacterial efficacy. The patent landscape summarized in Table 3 further reflects expanding technological interest in magnetic hyperthermia systems, catalytic nanozymes, antibiofilm coatings, implant-associated platforms, and multifunctional SPION formulations, although patent protection demonstrates technical novelty rather than clinical effectiveness or regulatory readiness. Translation is further complicated by the likely classification of SPION hyperthermia as a drug–device combination product, requiring integrated assessment of nanoparticle composition and manufacture, magnetic-field generation, treatment control, and biological performance. The FDA-approved Magtrace/Sentimag system provides an important regulatory precedent for clinical use of an iron oxide–device combination, but its diagnostic indication cannot be directly extrapolated to antibacterial therapy. Accordingly, the principal translational barriers remain the absence of dedicated antibacterial AMF trials, harmonized thermal and microbiological endpoints, and validated manufacturing and safety standards. Table 3Representative Patent Landscape for Antibacterial and Hyperthermia-Oriented SPION TechnologiesPatent/TitleAssigneePriority and StatusPrincipal ClaimAntibacterial RelevanceCritical LimitationUS 10,369,089 B2 (from US 2018/0028417 A1)Iron Oxide Nanoparticles and Methods of Use Thereof158The Trustees of the University of PennsylvaniaPriority: 13 Feb 2015Granted: 6 Aug 2019IONPs, optionally combined with H2O2 or enzymes, for degrading biofilm matrix, killing bacteria, and preventing biofilm formation on teeth, tissues, implants, and devices.Direct antibacterial IONP patent family supporting catalytic/nanozyme biofilm treatment.Does not principally claim AMF-induced magnetic hyperthermia.US 12,138,369 B2 (from US 2019/0209743 A1)Magnetically-Activated Coating for Treating Biofilms159University of Iowa Research FoundationPriority: 27 Jun 2016Granted: 12 Nov 2024; activeImplant coating containing magnetic particles in a polymer, activated by an AMF coil; includes temperature monitoring, zoned field delivery, and thermal treatment of device biofilms.Most directly relevant patent for localized magnetothermal eradication of implant-associated biofilms.Requires a pre-coated device and localized thermal-shock conditions rather than freely administered SPIONs.US 2023/0130513 A1Magnetic-Responsive Photosensitizer Nanoplatform and Uses Thereof160University of Maryland, BaltimorePriority: 21 Oct 2021Published: 27 Apr 2023; pendingSPION–photosensitizer microemulsion magnetically targeted into pathogenic oral biofilms during antimicrobial photodynamic therapy.Relevant to magnetic targeting and multimodal antibiofilm therapy.Bactericidal mechanism is photodynamic rather than magnetic heating.US 2023/0338575 A1Cobalt-Doped Iron Oxide Nanoparticles and Methods for Making and Using161Oregon Health and Science University and collaboratorsPriority: 21 Mar 2022Published: 26 Oct 2023; pendingNon-spherical cobalt-doped iron-oxide nanoparticles with high SAR, optional polymers and targeting ligands, and AMF exposure for hyperthermia.Addresses anisotropy, heating efficiency, and potential dose reduction relevant to antibacterial hyperthermia design.Primary indications are non-infectious; cobalt release and long-term toxicity require evaluation.WO 2025/090766 A1Superparamagnetic Polycrystalline Iron Oxide Nanoparticles for Magnetic Hyperthermia162University of South Florida; University of Houston System; University of South Florida St. PetersburgPriority: 27 Oct 2023Published: 1 May 2025; PCT pendingPolycrystalline iron-oxide super particles, approximately 150–400 nm, composed of sub-15 nm crystallites and designed to retain superparamagnetic with enhanced heating.Addresses the trade-off among particle size, aggregation, superparamagnetic, and high heat generation.Claims emphasize cancer hyperthermia; antibacterial efficacy is not established in the patent record. Representative Patent Landscape for Antibacterial and Hyperthermia-Oriented SPION Technologies Challenges and Prospects The development and application of IONPs in combating bacterial infections present several challenges. One of the primary challenges is the rapid emergence of multidrug-resistant and extensively drug-resistant bacterial strains, which limits the efficacy of conventional antibiotics and necessitates alternative therapeutic strategies such as IONPs.163 Ensuring consistent quality and reproducibility in IONP synthesis remains difficult due to variations in methods that affect their size, shape, and antibacterial properties.163,164 Additionally, while IONPs exhibit minimal cytotoxicity to mammalian cells, comprehensive in vivo studies are required to fully understand their long-term biocompatibility and potential side effects.165,166 Regulatory hurdles also pose a significant barrier, as the approval process for new nanomaterials is complex and time-consuming, requiring extensive safety and efficacy testing.167 Furthermore, scaling up the production of IONPs in a cost-effective manner is challenging, and the environmental implications of large-scale production and disposal need careful assessment to prevent ecological harm.164 Despite these challenges, the prospects for IONPs are promising. Advanced synthesis techniques, such as hybrid approaches combining top-down and bottom-up methods, can enhance the quality and functionality of IONPs.163,166,168 IONPs engineered for targeted drug delivery have the potential to deliver antibiotics and other therapeutic agents directly to infection sites, increasing treatment efficacies and reducing side effects.166 The development of multifunctional NPs with simultaneous antibacterial, imaging, and therapeutic capabilities could revolutionize the treatment of bacterial infections.169,170 Rigorous clinical trials are necessary to validate the safety and effectiveness of IONPs in humans, paving the way for their integration into standard medical practice.171,172 Moreover, the application of IONPs in tissue engineering and regenerative medicine holds promise for enhancing wound healing and repairing damaged tissues.169,171 Beyond medical applications, IONPs could be utilized in environmental cleanup processes, such as removing bacterial contaminants from water sources, highlighting their versatility. Increased collaboration between academia, industry, and regulatory bodies, coupled with substantial funding, can accelerate the development and deployment of IONPs as next-generation antimicrobial agents, address global health issues and advance the field of nanotechnology. Conclusion SPIONs represent a promising platform for the localized treatment of antibiotic-resistant and biofilm-associated infections because they combine remotely activated magnetic heating with catalytic, mechanical, drug-delivery, and imaging functions. The therapeutic performance is determined by the coupled effects of particle size, morphology, crystallinity, magnetic anisotropy, oxidation state, surface chemistry, aggregation, nanoparticle concentration, and alternating magnetic field conditions. These parameters govern specific absorption rate, intrinsic loss power, biofilm penetration, bacterial association, reactive oxygen species generation, and host-cell compatibility. Importantly, SPION-mediated treatment need not rely exclusively on high-temperature ablation. Mild hyperthermia can destabilize extracellular polymeric substances, increase membrane permeability, enhance antibiotic diffusion, promote biofilm dispersal, and amplify nanozyme-mediated oxidative stress while reducing injury to surrounding tissue. Multifunctional systems incorporating magneto-mechanical actuation, quorum-sensing interference, photodynamic therapy, thermoresponsive drug release, and implant coatings further expand the antibacterial potential of SPIONs. Nevertheless, translation remains limited by formulation variability, heterogeneous tissue accumulation, nonuniform thermal dosing, incomplete mechanistic resolution, inconsistent microbiological endpoints, and uncertainties concerning biodistribution, biodegradation, and long-term toxicity. Future progress will require quality-by-design manufacturing, standardized magnetic and thermal characterization, spatially resolved dosimetry, clinically relevant polymicrobial models, and integrated evaluation of antibacterial efficacy and host response. These advances could establish SPION-mediated magnetic hyperthermia as an effective adjunct for chronic wounds, dental infections, abscesses, and implant-associated biofilms. Acknowledgments We acknowledge financial support for this review from the National Science and Technology Council, Taiwan (NSTC 115-2113-M-038-003) and Taipei Medical University. Disclosure The authors declare that they have no competing interests. References